Atopic dermatitis is one of the most common causes of paediatric, dermatological and allergological consultation; it is characterized by chronic inflammation of the skin, affecting mainly paediatric patients [1,2]. It is manifested mostly as a mild disease according to the SCORAD score of symptoms (less than 15). Нere is a minority of individuals who have severe manifestations which are not only a diagnostic, also a therapeutic challenge claiming many therapeutic resources. Although this condition is not life-threatening, results in a decrease in their life quality as well as their families, sleep disturbances, increased anxiety, family dysfunction and varying in intensity depending on the severity and comorbidities >3-.Нe prevalence varies globally between 5-15% 6 and certainly there has been an increase in both prevalence and incidence of the disease [7] especially in Westernized countries.